First Time Loading...

Halozyme Therapeutics Inc
NASDAQ:HALO

Watchlist Manager
Halozyme Therapeutics Inc Logo
Halozyme Therapeutics Inc
NASDAQ:HALO
Watchlist
Price: 44.75 USD -1.41% Market Closed
Updated: May 18, 2024

Halozyme Therapeutics Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Halozyme Therapeutics Inc
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Halozyme Therapeutics Inc
NASDAQ:HALO
Total Other Income
$13.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Other Income
-$4.7B
CAGR 3-Years
6%
CAGR 5-Years
-204%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$252m
CAGR 3-Years
22%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$151m
CAGR 3-Years
126%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$15.3m
CAGR 3-Years
N/A
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
-$31.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Halozyme Therapeutics Inc's Total Other Income?
Total Other Income
13.2m USD

Based on the financial report for Mar 31, 2024, Halozyme Therapeutics Inc's Total Other Income amounts to 13.2m USD.